Jul 6, 2026

Building future-fit MEX programmes for modern pharma marketing

Authored by Marie Little, and Gareth Hall, Client Partners and Adrianna Marino, Senior Consultant.

In a previous article authored by Marie Little and Stephanie Hall, we explored the marketing capabilities pharma and biotech teams will need to strengthen by 2030, from insight and behavioral orchestration through to smart analytics, ecosystem collaboration and scientific-patient storytelling. The clear message was that marketing capability is evolving quickly, and that teams must build for a more complex, more connected and more demanding commercial environment.

The next question is a more practical one: what does a great Marketing Excellence, or MEX, program look like for organizations facing that future?

Across the organizations we work with, the most effective MEX programs have moved well beyond annual training calendars or standalone skills modules. Increasingly, they are being used as a strategic response to bigger organizational change: shifting portfolio priorities, more specialized assets, evolving global-to-local operating models, increasing launch intensity, new customer expectations and a greater need for data-driven decision-making.

In that context, MEX is about helping teams operate with greater consistency, confidence and commercial impact in a business that has changed around them. The strongest programs are rooted in live business priorities, connected to cross-functional ways of working and focused on the behaviors that improve the quality of strategic decision-making.

From training to transformation

Marketing Excellence can sometimes become too broad to be useful. It can include brand planning, segmentation, omnichannel, launch excellence, customer engagement, insight generation, content strategy, agency management, performance measurement and leadership behaviors. All of these are important, but the value comes from connecting them into a clear, practical capability architecture that supports the strategic vision of the business.

For many pharma organizations, this means building marketing capability that reflects a more specialized, more launch-focused and more digitally enabled commercial model, which also underpins seamless cross-functional orchestration. MEX becomes an enabler of commercial transformation, helping the organization build the standards, behaviors and ways of working needed for its next stage of growth.

That means defining what good looks like for a junior marketer, what great looks like for a local marketing lead, and what excellence looks like for a senior global brand director. It also means recognizing that capability builds over time. Senior leaders need to coach, challenge and shape strategic direction. Mid-level marketers need to translate strategy into focused plans. More junior marketers need to build strong foundations in insight, customer understanding, content, execution and measurement.

A future-fit MEX program creates a shared language across all these levels. It helps teams understand the standards expected of them, while giving leaders a more consistent way to support development and build maturity across the organization.

Start with the business shift

A modern MEX program should begin with the business context, because capability only matters if it helps teams respond to the realities they are facing.

For some organizations, that reality is a changing portfolio mix, with more specialist brands, smaller patient populations or more complex treatment pathways. For others, it is a new operating model that demands tighter collaboration between global, regional and local teams. Many are also managing compressed launch timelines, increased competitive pressure, more demanding customers and a growing expectation that omnichannel activity is measurable, connected and commercially meaningful.

These shifts change what marketers need to be good at. They need to move faster from insight to impact. They need to design customer journeys that connect content, channels and field engagement. They need to work more effectively with medical, market access, digital and analytics colleagues. They need to make sharper choices about where to focus, what to prioritize and how to measure impact.

This is where Marketing Excellence gets exciting, because it can help organizations work differently. It can connect capability building to the commercial decisions, customer experiences and cross-functional behaviors that will determine future performance.

The new standard: insight-led, adaptive and commercially sharp

The next generation of Marketing Excellence will be more connected to data, faster in its application and more focused on behavior change. It will help marketers use AI, analytics and automation with confidence, while strengthening the human capabilities that remain essential: judgment, interpretation, creativity, influence and constructive challenge.

It will also help teams design more connected customer experiences. In practical terms, this means moving from channel utilization to journey orchestration, where webinars, virtual engagement, portals, email, field teams and content ecosystems work together to move customers from awareness to action.

This is especially important as more organizations look to build modern specialty pharma models, where success depends on deeper customer understanding, stronger launch readiness, more precise engagement and better cross-functional execution. In these environments, marketing needs to be both strategically sharp and operationally connected.

Four shifts are particularly important.

1. Future-fit MEX improves the quality of commercial decisions

MEX has evolved from teaching marketing tools into improving the decisions marketers make every day. The best programs help teams ask better questions before they commit to a plan: what do we know, and what are we assuming? What behavior are we trying to change? What choices will create the greatest impact? How will we learn quickly and adapt?

These questions may sound simple, but they are often where marketing excellence is won or lost.

2. Challenger thinking becomes a core marketing capability

In pharma and biotech, brand teams are often highly experienced, deeply knowledgeable and have a good understanding of their patients’ lived experience. This combination is a major strength, although it can also create blind spots. Teams can become attached to established assumptions about customers, competitors, patient journeys or market dynamics, or even company and leadership expectations. Plans can become incremental, and strategies can feel internally coherent without being sufficiently distinctive externally.

Challenger thinking gives teams a practical way to test the quality of their thinking before decisions become locked in. At its best, it is disciplined, evidence-led and constructive. It encourages teams to ask whether the positioning is genuinely differentiated, whether segments are helping them make different choices, whether content is built around a real customer need, and whether they could be more creative in problem-solving to open up opportunities competitors have not spotted.

These questions create useful pressure, improving the quality of strategic debate across functions and helping teams make braver, more commercially relevant choices.

3. Capability is built through live business problems

The most effective MEX programs ‘make it real’ by anchoring in live business challenges, whether that means pressure testing an active brand plan, redesigning a customer journey, sharpening a content strategy, reviewing launch readiness, mapping cross-functional roles or strengthening performance measures for an upcoming campaign.

These short-term wins matter because they build momentum. They show teams that Marketing Excellence is practical, commercially relevant and capable of delivering value quickly.

4. The best MEX programs become part of the operating rhythm

Capability is sustained through everyday practice. Great programs provide simple tools, rituals and expectations that become part of how teams work, such as insight challenge sessions, content audit guides, journey planning templates, RACI guides, strategy pressure testing, performance review forums and insight-to-impact planning tools.

They also need visible leadership sponsorship. Leaders must set expectations, role model the behaviors and create the space for teams to challenge, test and learn. In many organizations, there is also value in aligning marketing capability with wider functional frameworks, such as medical affairs competency models, so that maturity can develop in parallel across functions.

This is where MEX starts to feel less like a program and more like an operating system for commercial excellence. It becomes a practical way to build consistency across markets, strengthen global-to-local execution and embed the behaviors needed for transformation.

How Prescient works with pharma marketing leaders

We start by being clear on the role Marketing Excellence needs to play in your organization. The priority may be to raise the quality of brand strategy, build stronger launch readiness, embed omnichannel transformation, improve cross-functional working, strengthen content strategy, accelerate adoption of AI and analytics, or develop commercial leadership capability.

From there, our team of experts design the program around the decisions, behaviors and standards that will make the biggest difference to the business you are becoming. We build in challenger thinking early, giving teams both the permission and the structure to ask better questions, pressure test assumptions, and improve the quality of strategic debate.

We will always make the program practical, so we will use live work, create tools that teams will use, manage stakeholders and involve leaders, then build-in measurement of progress – monitoring the quality of decisions, the consistency of execution and the impact on performance.

With Prescient’s partnership, you can expect MEX programs to help you build the commercial muscle needed for your next stage of growth and create teams who are sharper, braver and more effective at turning insight into strategy, strategy into action, and action into measurable impact.

Request a call to discuss how we can build a future-fit MEX program, fully tailored to your team and priorities. 

Contact us

Whether you're exploring a new opportunity or looking for strategic support, we’d love to hear from you.
Find out more
Contact us

Latest Resources

Explore our latest insights, whitepapers, and event highlights to learn more about the latest developments and perspectives shaping the evolving healthcare landscape.

View all

Get in Touch

Reach out to explore how we can
support your goals

If you're interested in learning more about our services or would like to speak with the team, please get in touch.

Contact us